Literature DB >> 25654501

Grey matter atrophy in mild cognitive impairment / early Alzheimer disease associated with delusions: a voxel-based morphometry study.

Windsor Kwan-Chun Ting, Corinne E Fischer, Colleen P Millikin, Zahinoor Ismail, Tiffany W Chow, Tom A Schweizer1.   

Abstract

OBJECTIVES: Grey matter atrophy in the right hemisphere has been shown to be more severe in dementia patients with delusions, suggesting a neuroanatomical localization that may be pertinent to impending neurodegeneration. Delusional symptoms may arise when atrophy in these areas reduces the regulatory functions of the right hemisphere, in tandem with asymmetric neuropathology in the left hemisphere. We hypothesized that delusional patients with either amnestic mild cognitive impairment (MCI) or early Alzheimer Disease (AD) would experience more pronounced grey matter atrophy in the right frontal lobe compared with matched patients without delusions.
METHODS: We used neuroimaging and clinical data obtained from the Alzheimer's Disease Neuroimaging Initiative. A comparison group of twenty-nine nondelusional MCI/early AD participants were compared with twenty-nine delusional participants using voxel-based morphometry, matched at baseline by age, sex, education, and Mini-Mental State Exam score. All included participants were diagnosed with amnestic MCI at study baseline.
RESULTS: Fifteen voxel clusters of decreased grey matter in participants with delusions were detected. Prominent grey matter decrease was observed in the right precentral gyrus, right inferior frontal gyrus, right insula, and left middle occipital gyrus, areas that may be involved in control of thought and emotions.
CONCLUSION: Greater right fronto-temporal grey matter atrophy was observed in MCI or early AD participants with delusions compared to matched patients without delusions. Consistent with our predictions, asymmetric grey matter atrophy in the right hemisphere may contribute to development of delusions through loss of executive inhibition.

Entities:  

Mesh:

Year:  2015        PMID: 25654501     DOI: 10.2174/1567205012666150204130456

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  18 in total

1.  Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.

Authors:  Corinne E Fischer; Winnie Qian; Tom A Schweizer; Colleen P Millikin; Zahinoor Ismail; Eric E Smith; Lisa M Lix; Paul Shelton; David G Munoz
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

2.  Gray Matter Changes Associated With the Development of Delusions in Alzheimer Disease.

Authors:  Winnie Qian; Tom A Schweizer; Nathan W Churchill; Colleen Millikin; Zahinoor Ismail; Eric E Smith; Lisa M Lix; David G Munoz; Joseph J Barfett; Tarek K Rajji; Corinne E Fischer
Journal:  Am J Geriatr Psychiatry       Date:  2018-10-02       Impact factor: 4.105

Review 3.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

4.  Gray matter atrophy in patients with mild cognitive impairment/Alzheimer's disease over the course of developing delusions.

Authors:  Corinne E Fischer; Windsor Kwan-Chun Ting; Colleen P Millikin; Zahinoor Ismail; Tom A Schweizer
Journal:  Int J Geriatr Psychiatry       Date:  2015-03-27       Impact factor: 3.485

Review 5.  Neuropsychiatric Symptoms in Mild Cognitive Impairment.

Authors:  Damien Gallagher; Corinne E Fischer; Andrea Iaboni
Journal:  Can J Psychiatry       Date:  2017-03       Impact factor: 4.356

6.  Possible clinical anatomical features of right Alzheimer's disease (RAD).

Authors:  Carlo Abbate; Pietro D Trimarchi; Silvia Inglese; Emanuele Tomasini; Alessia Gallucci; Sarah Damanti; Simona Ciccone; Paolo D Rossi; Daniela Mari; Beatrice Arosio; Renzo Bagarolo; Fabrizio Giunco; Matteo Cesari
Journal:  Aging Clin Exp Res       Date:  2020-05-01       Impact factor: 3.636

7.  Causal structural covariance network revealing atrophy progression in Alzheimer's disease continuum.

Authors:  Zhao Qing; Feng Chen; Jiaming Lu; Pin Lv; Weiping Li; Xue Liang; Maoxue Wang; Zhengge Wang; Xin Zhang; Bing Zhang
Journal:  Hum Brain Mapp       Date:  2021-05-12       Impact factor: 5.038

Review 8.  Role of Hybrid Brain Imaging in Neuropsychiatric Disorders.

Authors:  Amer M Burhan; Nicole M Marlatt; Lena Palaniyappan; Udunna C Anazodo; Frank S Prato
Journal:  Diagnostics (Basel)       Date:  2015-12-04

Review 9.  Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms.

Authors:  Krista L Lanctôt; Joan Amatniek; Sonia Ancoli-Israel; Steven E Arnold; Clive Ballard; Jiska Cohen-Mansfield; Zahinoor Ismail; Constantine Lyketsos; David S Miller; Erik Musiek; Ricardo S Osorio; Paul B Rosenberg; Andrew Satlin; David Steffens; Pierre Tariot; Lisa J Bain; Maria C Carrillo; James A Hendrix; Heidi Jurgens; Brendon Boot
Journal:  Alzheimers Dement (N Y)       Date:  2017-08-05

10.  Abnormal global functional network connectivity and its relationship to medial temporal atrophy in patients with amnestic mild cognitive impairment.

Authors:  Can Sheng; Mingrui Xia; Haikuo Yu; Yue Huang; Yan Lu; Fang Liu; Yong He; Ying Han
Journal:  PLoS One       Date:  2017-06-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.